New York · A career in signals
Elina Scherwitzl was five when the universe first became a problem worth solving. Her father talked to her about planets, stars and the stubborn mechanics of how everything fits together. For a child growing up in Malmö, the scale was delightfully unreasonable. Physics offered a grammar for wonder, so she followed it: engineering physics at Lund, doctoral work through the University of Geneva, then the ATLAS experiment at CERN. By the time the world learned in 2012 that a Higgs-like particle had appeared in the data, Scherwitzl had spent years among people trained to distrust an exciting answer until the evidence could survive them.
That apprenticeship matters because her second career is often told as a charming swerve. Particle physicist leaves CERN, writes an app, becomes founder. The clean arc disguises the continuity. Scherwitzl did not abandon the habit of physics. She redirected it from collisions inside the Large Hadron Collider to patterns generated quietly by the human body. In both places the task was to find a small signal inside abundant noise, then say precisely how sure you were.
A private calculation finds a public life
The first version of Natural Cycles was not born in a brainstorm with sticky notes. Scherwitzl wanted a reliable way to understand her own fertility, so she began recording her temperature and reading the existing research. Basal body temperature shifts after ovulation. The measurement itself was ordinary; the interesting question was what an algorithm could responsibly conclude from it. Her own readings became part of the earliest dataset. Later, data from early users and published research involving thousands of women helped shape the model.
Raoul Scherwitzl, a fellow physicist whom she had met while studying in the United States and later married, recognized a product in the calculation. On their honeymoon, he suggested turning it into an app. This is the sort of origin detail that sounds invented by a publicist, except it has the pleasing domestic absurdity of truth: two newlyweds, one algorithm, and apparently no firm rule against discussing scalable software.
“I could see that so many women would benefit from it.”Elina Scherwitzl, on the decision to build the app
The division of labor was not yet very divided. Scherwitzl wrote the algorithm. She coded the app. She designed the first website and answered customer-support messages. She calls herself “Cycler number one,” but she was also employee number one, an entire product department arranged behind a single laptop. The company was founded in 2013 and launched in Sweden in 2014 after the couple moved to Stockholm.
There was an audacious premise beneath the homespun beginnings. Natural Cycles would be consumer software, but its central claim would be treated as a medical-device claim. Pretty interfaces and app-store enthusiasm could not carry that burden. Evidence, documentation and regulatory review would.
The years between an idea and a category
Europe certified Natural Cycles as a contraceptive medical device in 2017. In August 2018, the US Food and Drug Administration granted De Novo clearance, creating a new regulatory classification for software used for contraception. Natural Cycles became the first birth control app cleared by the agency. The milestone changed the company and, in the same year, Scherwitzl moved with her family to the New York area to build its American presence.
Clearance did not confer immunity from criticism. A product that asks people to act on a daily status carries consequences that a meditation timer does not. Reports of unintended pregnancies in Sweden prompted a regulator's investigation. The eventual finding said the reported number was consistent with the product's expected failure rate, while requiring clearer communication of risk. A British advertising ruling separately found that an ad using “highly accurate” was misleading. Scherwitzl agreed that effectiveness, not accuracy, was the proper language.
There is character in that correction. Founders are rewarded for certainty, often long after certainty has stopped being useful. Scherwitzl had entered a field where precision includes saying what a product cannot promise. The scrutiny was bruising, but it also exposed the distinction at the center of her work: an algorithm can calculate; a person must still use what it says correctly.
A physicist learns the consumer
At CERN, discovery was communal and vast. The ATLAS collaboration involved thousands of scientists, and no sensible account turns one contributor into the discoverer of the Higgs boson. Scherwitzl's role was real but properly collective. Startup mythology prefers the opposite arrangement: a lone genius, one revelation, a market obediently transformed. Natural Cycles fits neither story. Its founder built the original technology herself, then spent more than a decade constructing teams and institutions around it.
Her education in consumer behavior came quickly. A model can be statistically coherent and still meet a sleepy user who forgets a measurement. It can be explained in documentation and misunderstood in an advertisement. It can improve while the public assumes “software” means casual updates. Scherwitzl's company had to make a complex calculation legible in two colors: green for days the system identifies as not fertile, red for days when users should use protection or abstain if avoiding pregnancy. Considerable science ends in a screen deliberately short on suspense.
Signal → decision
Temperature data enters the model. The model estimates a fertile window. The interface turns probability into a daily status. Regulation governs the claim. The user still governs the action.
Wearables changed the ritual. Instead of relying only on a thermometer reading after waking, compatible devices could collect temperature data overnight. The FDA cleared integration with Oura Ring in 2021 and Apple Watch in 2023. A 2024 clearance established a predetermined route for additional hardware changes. Later integrations and the company's own band moved the product toward passive collection without removing the central obligation to interpret data conservatively.
This is where Scherwitzl's two professional worlds meet most neatly. Particle detectors do not hand scientists meaning; they produce signals that require calibration, models and doubt. Consumer sensors are humbler machines, but the intellectual choreography is related. A reading is not a conclusion. The interesting work lives between them.
Proof, revised in public
Natural Cycles raised a $55 million Series C in 2024, led by Lauxera Capital Partners, with participation from Point72 Private Investments and a debt facility from J.P. Morgan. The money was allocated to commercial growth, product development and automating reimbursement. By then, the company had crossed from disputed startup into durable institution, without escaping the productive discomfort of being examined.
In 2026 it announced a sixth FDA clearance, this time for a next-generation algorithm combining statistical modeling with machine learning trained on tens of millions of data points. The sequence of clearances is more revealing than any single certificate. In regulated software, launch is not a finish line. Each new sensor, claim or model change creates another appointment with evidence.
ATLAS experiment at CERN during the Higgs boson search.
Natural Cycles is founded; Scherwitzl builds the first algorithm and app.
European certification, then the first US FDA clearance for a birth control app.
FDA-cleared integrations bring overnight wearable data into the product.
A $55 million Series C, new hardware and a sixth FDA clearance.
She has also accumulated the conventional laurels of a technology founder: a place on Forbes' 2018 list of leading women in technology, industry awards, a role on the CERN Alumni Advisory Board, and recognition in the Inc. Female Founders 500 for 2026. They make a handsome shelf. Her more distinctive achievement is category work. She helped persuade institutions that an app could be considered contraception, then accepted the unusual accountability that followed.
“Natural Cycles plays a huge role in women's lives, which humbles us.”Elina Scherwitzl
The long experiment
Scherwitzl describes herself as someone who likes to plan and optimize. It is an unsurprising confession from a physicist who became a chief executive, although entrepreneurship has a talent for humiliating plans. Her career contains discovery, public argument, regulatory setbacks, fundraising and relocation. The useful constant is not perfect foresight. It is her willingness to treat each stage as another set of observations.
She has said that gut feeling is the combination of one's experiences and thoughts. That definition rescues intuition from mysticism and makes it sound almost computational. Experience accumulates; judgment compresses it; a decision appears. Perhaps this is how a scientist permits herself to be a founder, in a life where some choices arrive before a complete dataset.
The little girl in Malmö wanted to know how everything fit together. At CERN, that curiosity joined one of science's largest collaborations. At Natural Cycles, it entered a phone, a regulatory file and millions of daily routines. The scales could hardly be more different. Yet Scherwitzl has spent both careers doing the same elegant, difficult thing: looking at what is hard to see, measuring carefully, and making an argument that other people can test.
The work after launch
Published research, countries of availability and FDA clearances are different measures. The bars show the breadth of the continuing program, not a common scale.